183 related articles for article (PubMed ID: 1847559)
1. Prevalence of antibody to hepatitis C virus in a blood donor population.
Richards C; Holland P; Kuramoto K; Douville C; Randell R
Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
[TBL] [Abstract][Full Text] [Related]
2. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
4. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
7. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
Jullien AM; Couroucé AM; Massari V; Maniez M; Finetti P; Brevière D; Girard M; Andréani T; Habibi B
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):668-72. PubMed ID: 8243482
[TBL] [Abstract][Full Text] [Related]
8. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-hepatitis C virus in the blood donor population of Rio de Janeiro.
Vanderborght BO; Reis AM; Rouzere CD; da Silva RS; Yoshida CF; Franco LG; Maertens G; Van Heuverswijn H; Moreira Pereira J
Vox Sang; 1993; 65(2):122-5. PubMed ID: 7692672
[TBL] [Abstract][Full Text] [Related]
11. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
[TBL] [Abstract][Full Text] [Related]
12. Recombinant immunoblot assay first and second generations on 732 blood donors reactive for antibodies to hepatitis C virus by ELISA. The Hepatitis Study Group of the French Society of Blood Transfusion.
Couroucé AM; Janot C
Vox Sang; 1991; 61(3):177-80. PubMed ID: 1666933
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
[TBL] [Abstract][Full Text] [Related]
14. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
Ebeling F
Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
16. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
[TBL] [Abstract][Full Text] [Related]
18. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
Bettigole R; Shastri KA
J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
[TBL] [Abstract][Full Text] [Related]
20. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
